Patent details

LUC00048 Product Name: "Ribociclib ou un sel pharmaceutiquement acceptable de celui-ci"

Basic Information

Publication number:
LUC00048
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP097820518
Legal Status:
Inactive
Application number:
LUC00048
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/171221
Marketing Authorization Type:
Marketing Authorization Date:
24/08/2017
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
09/11/2017
First Marketing Authorization date:
24/08/2017
Grant date:
10/01/2018
Activation date:
Publication date:
15/11/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/08/2032
SPC Extension Expiration:
24/08/2032
Rejection date:
Withdrawal date:

Owner

From:
09/11/2017
 
 

Name:
Astex Therapeutics Ltd.
Address:
436 Cambridge Science Park Milton Road, Cambridge CB4 0QA, United Kingdom (GB)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
09/11/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2018/01
Publication date:
15/01/2018
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/03
Publication date:
20/02/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
31/08/2029
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
15/11/2017 Publication 1
15/11/2017 Outgoing Correspondence 1
10/01/2018 FNET_DC_FRONTPAGE 1
09/11/2017 General Document 2
10/01/2018 Certificate 1
09/11/2017 Application Form 4
15/11/2017 General Document 3
09/11/2017 General Document 41
10/01/2018 Publication 1